Essential fatty acids in the nutrition of severely neurologically disabled children

British Journal of Nutrition

Volumn 83, Issue 3, 2000, Pages 219-225

  Hals, Jardar ^a   Bjerve, K S ^b   Nilsen, H ^c   Svalastog, A G ^a   Ek, J ^a  

^a Buskerud Central Hospital   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BENZODIAZEPINE; CARBAMAZEPINE; CHLORTETRACYCLINE; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; FISH OIL; LAMOTRIGINE; LINOLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHENOBARBITAL; SOYBEAN OIL; TRIACYLGLYCEROL; VALPROIC ACID; VITAMIN;

ADOLESCENT; ARTICLE; CHILD; CHILD NUTRITION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; ENERGY CONSUMPTION; FEMALE; HANDICAPPED CHILD; HUMAN; LIPID BLOOD LEVEL; MALE; NEUROLOGIC DISEASE;

GLYCINE MAX;

EID: 0034007592     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0007114500000283     Document Type: Article

References (41)

1. Agostoni C, Trojan S, Bellu R, Riva E & Giovannini M (1995) Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice: the role of long-chain polyunsaturated fatty acids. Pediatric Research 38, 262-266.
2. Aman MG, Mitchell EA & Turbott SH (1987) The effects of essential fatty acid supplementation by Efamol in hyperactive children. Journal of Abnormal Child Psychology 15, 75-90.
3. Andersen LF, Solvoll K & Drevon CA (1996) Very-long-chain n-3 fatty acids as biomarkers for intake of fish and n-3 fatty acid concentrates. American Journal of Clinical Nutrition 64, 305-311.
4. Berg K (1973) Nutrition of children with reduced physical activity due to cerebral palsy. Bibliotheca Nutriteo et Dieta 19, 12-20.
5. Bjerve KS, Brubakk AM, Fougner KJ, Johnsen H, Midthjell K & Vik T (1993) Omega-3 fatty acids: essential fatty acids with important biological effects, and serum phospholipid fatty acids as markers of dietary ω3-fatty acid intake. American Journal of Clinical Nutrition 57, Suppl., 801S-806S.
6. Bjerve KS, Fischer S & Aime K (1987) Alpha-linolenic acid deficiency in man: effect of ethyl linolenate on plasma and erythrocyte fatty acid composition and biosynthesis of prostanoids. American Journal of Clinical Nutrition 46, 570-576.
7. Bjerve KS, Fischer S, Wammer F & Egeland T (1989) a-Linolenic acid and long-chain ω-3 fatty acid supplementation in three patients with ω-3 fatty acid deficiency: effect on lymphocyte function, plasma and red cell lipids, and prostanoid formation. American Journal of Clinical Nutrition 49, 290-300.
8. Bjerve KS, Thoresen L & Børsting S (1988) Linseed and cod liver oil induced rapid growth in a 7-year old girl with n-3 fatty acid deficiency. Journal of Parenteral and Enterai Nutrition 12, 521-525.
9. Blaker B & Rimestad AH (1991) Food Composition Tables. Oslo: National Nutrition Council.
10. Bønaa KH, Bjerve KS & Nordøy A (1992a) Habitual fish consumption, plasma phospholipid fatty acids and serum lipids: the Tromsø study. American Journal of Clinical Nutrition 55, 1126-1134.
11. Bønaa KH, Bjerve KS & Nordøy A (19926) Docosahexaenoic and eicosapentaenoic acids in plasma phospholipids are divergently associated with high density lipoprotein in humans. Arteriosclerosis and Thrombosis 12, 675-681.
12. Carlson SE, Werkman SH, Rhodes PG & Tolley EA (1993) Visualacuity development in healthy preterm infants: effect of marine oil supplementation. American Journal of Clinical Nutrition 58, 35-42.
13. Carlson SE & Wilson WW III (1994) Docosahexaenoic acid supplementation of preterm infants: effect on the 12-month Bayley mental developmental index. Pediatric Research 35, 20A.
14. Connor WE, DeFrancesco CA & Connor SL (1993) N-3 fatty acids from fish oil. Effects on plasma lipoproteins and hypertriglyceridemic patients. Annals of the New York Academy of Sciences 683, 16-34.
15. Crawford MA, Costeloe K, Doyle W, Leighfield MJ, Lennon EA & Meadows N (1990) Potential diagnostic value of the umbilical artery as a definition of neural fatty acid status of the fetus during its growth: the umbilical artery as a diagnostic tool. Biochemical Society Transactions 18, 761-766.
16. Crawford MA, Doyle W, Drury P, Lennon A, Costeloe K & Leighfield M (1989) n-6 and n-3 fatty acids during early human development. Journal of Internal Medicine 225, Suppl. 1, 159-169.
17. Decsi T & Koletzko B (1994) Polyunsaturated fatty acids in infant nutrition. Acta Pædiatrica 395, Suppl., 31-37.
18. Decsi T & Koletzko B (1995) Growth, fatty acid composition of plasma lipid classes, and plasma retinol and a-tocopherol concentrations in full-term infants fed formula enriched with ω-6 and ω-3 long-chain polyunsaturated fatty acids. Acta Pædiatrica 84, 725-732.
19. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Canon JG, Rogers TS, Klempner MS, Weber PC, SchaeferEJ, Sheldon MW & Dinarello CA (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. New England Journal of Medicine 320, 265-271.
20. Hagve TA & Christophersen BO (1984) Effect of dietary fats on arachidonic acid and eicosapentaenoic acid biosynthesis and conversion to C22 fatty acids in isolated rat liver cells. Biochimica et Biophysica Acta 796, 205-217.
21. Hals J, Ek J, Svalastog AG & Nilsen H (1996) Studies on nutrition in severely neurologically disabled children in an institution. Acta Pædiatrica 85, 1469-1475.
22. Harris WS (1989) Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. Journal of Lipid Research 30, 785-807.
23. Holman RT (1978) How essential are essential fatty acids? Journal of the American Oil Chemists' Society 55, 774A-780A.
24. Koletzko B (1997) Trans-fatty acids. Dietary fats in infancy and childhood. Annales Nestlé 55, 63-72.
25. Koletzko B, Edenhofer S, Lipowsky G & Reinhardt D (1995) Effects of a low birthweight infant formula containing human milk levels of docosahexaenoic and arachidonic acids. Journal of Pediatric Gastroenterology and Nutrition 21, 200-208.
26. Makrides M, Neumann M, Simmer K, Pater R & Gibson R (1995) Are long-chain polyunsaturated fatty acids essential nutrients in infancy? Lancet 345, 1463-1468.
27. Martinez M (1991) Developmental profiles of polyunsaturated fatty acids in the brain of normal infants and patients with peroxisomal diseases: severe deficiency of docosahexaenoic acid in Zellweger's and pseudo-Zellweger's syndromes. In Health Effects of Omega-3 Polyunsaturated Fatty Acids in Seafoods, pp. 87-102 [AP Simopoulos, RR Kifer, RE Martin and SM Barlow, editors]. Basel: Karger.
28. Mead JF & Slaton WH (1955) Metabolism of essential fatty acids III. Isolation of 5,8,11-eicosatrienoic acid from fat-deficient rats. Journal of Biology and Chemistry 219, 705-709.
29. Mitchell EA, Aman MG, Turbott SH & Manku M (1987) Clinical characteristics and serum essential fatty acid levels in hyperactive children. Clinical Pediatrics 26, 426-431.
30. National Research Council (1989) Recommended Dietary Allowances, 10th ed. Washington, DC: National Academy of Sciences.
31. Neuringer M, Connor WE, Lin DS, Barstad L & Luck S (1986) Biochemical and functional effects of prenatal and postnatal ω3 fatty acid deficiency on retina and brain in rhesus monkeys. Proceedings of the Motional Academy of Sciences USA 83, 4021-4025.
32. Rivers JPW & Frankel TL (1981) Essential fatty acid deficiency. British Medical Bulletin 37, 59-64.
33. Robinson DR (1987) Lipid mediators of inflammation. Rheumatic Diseases Clinics of North America 13, 385-405.
34. Sandstrøm BM, Aro A, Becker W, Lyhne N, Pedersen JI & Tòrsdòttir I (1996) Nordiska Näringsrekommendationer NORD 28, 14-15.
35. Shrapnel WS, Calvert GD, Nestel PJ & Truswell AS (1992) Diet and coronary heart disease. Medical Journal of Australia 156, Suppl., 9-16.
36. Statens livsmedelsverk (1993) Livsmedeltahell, Energi och Næringsemmen (Table of Food Energy and Nutrition). Uppsala: Statens livsmedelsverk.
37. Stevens LJ, Zentall SS, Deck JL, Abate ML, Watkins BA, Lipp SR & Burgess JR (1995) Essential fatty acid metabolism in boys with attention deficit - hyperactivity disorder. American Journal of Clinical Nutrition 62, 761-768.
38. Svennerholm L (1968) Distribution and fatty acid composition of phosphoglycerides in normal human brain. Journal of Lipid Research 9, 570-579.
39. Svensson BG, Akesson B, Nilsson A & Skerfving S (1993) Fatty acid composition of serum phosphatidylcholine in healthy subjects consuming varying amounts of fish. European Journal of Clinical Nutrition 47, 132-140.
40. Uauy-Dagach R, Mena P & Hoffmann DR (1994) Essential fatty acid metabolism and requirements for LBW infants. Acta Pædiatrica 405, Suppl., 78-85.
41. Willatts P, Forsyth JS, CiModugno MK, Varma S & Colvin M (1998) Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at ten months of age. Lancet 352, 688-691.